Category: Knowledge Hub

A European Salk Institute Could Ensure Accessible and Affordable Medicines

Medicine For All: The Case for a Public Option in the Pharmaceutical Industry

PBM, Procurement, and production: Public Pharma strategies for state to lower insulin prices

What is a Public-Commons Partnership?

Lenacapavir: quanto custa defender a saúde pública?

Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug

Gegen die Normalisierung des Absurden

29 years without Jonas Salk: against the normalization of the absurd

Patentes: Jonas Salk, contra a normalização do absurdo

Access to oncology medicines in EU and OECD countries

Keep In Touch